SEI INVESTMENTS CO - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,690,584
+7.4%
96,447
+1.5%
0.02%
+10.5%
Q2 2023$10,884,023
-26.0%
95,041
-11.0%
0.02%
-29.6%
Q1 2023$14,714,100
+196.4%
106,752
+178.6%
0.03%
+145.5%
Q4 2022$4,964,365
-49.3%
38,311
-56.7%
0.01%
-50.0%
Q3 2022$9,790,000
+105.5%
88,575
+39.4%
0.02%
+120.0%
Q2 2022$4,765,000
+121.3%
63,550
+131.4%
0.01%
+150.0%
Q1 2022$2,153,000
+59.5%
27,459
+83.3%
0.00%
+33.3%
Q4 2021$1,350,000
-21.1%
14,984
-19.0%
0.00%
-25.0%
Q3 2021$1,710,000
+27.7%
18,489
+7.4%
0.00%
+33.3%
Q2 2021$1,339,000
-7.3%
17,221
-3.6%
0.00%
-25.0%
Q1 2021$1,444,000
-76.9%
17,864
-51.2%
0.00%
-75.0%
Q4 2020$6,242,000
-15.2%
36,593
-30.2%
0.02%
-23.8%
Q3 2020$7,363,000
-10.9%
52,433
+1.7%
0.02%
-19.2%
Q2 2020$8,263,000
+57.5%
51,539
-4.0%
0.03%
+36.8%
Q1 2020$5,248,000
-13.1%
53,707
+14.7%
0.02%
+5.6%
Q4 2019$6,039,000
+52.3%
46,825
-11.1%
0.02%
+80.0%
Q3 2019$3,964,000
-52.4%
52,666
-3.9%
0.01%
-63.0%
Q2 2019$8,323,000
+32.8%
54,780
+4.1%
0.03%
+28.6%
Q1 2019$6,268,000
-35.5%
52,611
-14.3%
0.02%
-40.0%
Q4 2018$9,712,000
+4.6%
61,411
+6.9%
0.04%
+2.9%
Q3 2018$9,282,000
+28.8%
57,471
+5.4%
0.03%
+41.7%
Q2 2018$7,207,000
+109.1%
54,518
+17.2%
0.02%
+84.6%
Q1 2018$3,446,000
+88.1%
46,506
+41.3%
0.01%
+116.7%
Q4 2017$1,832,000
+80.8%
32,917
+47.4%
0.01%
+50.0%
Q3 2017$1,013,00022,3380.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders